DAB2 and hepatocellular carcinoma: Since DAB2 negatively regulates Ras by competing with son of sevenless homolog binding to growth factor receptor-bound protein 2, disrupting the formation of the latter complex, and suppressing consequent activation of Ras [46], may be one mechanism whereby SCFAs delay the pathogenesis of HCC.